EDITORIAL
Published on 27 Jul 2022
Editorial: Response assessment of radioligand therapies
doi 10.3389/fonc.2022.904337
- 1,249 views
- 1 citation
- Frontiers in Oncology
- Cancer Imaging and Image-directed Interventions
- Research Topics
- Response Assessment of Radioligand Therapies
Response Assessment of Radioligand Therapies
4,695
Total downloads
15k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 07 Apr 2022
Percentage of Tumor Invasion at Pretreatment High-Resolution Magnetic Resonance Imaging: Associating With Aggressive and Tumor Response in Chinese T3 Rectal Cancer-Preliminary Results
doi 10.3389/fonc.2022.616310
- 892 views
- 2 citations
ORIGINAL RESEARCH
Published on 17 Mar 2021
In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2nd Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With 177Lu-PSMA
doi 10.3389/fonc.2021.578093
- 2,866 views
- 19 citations
ORIGINAL RESEARCH
Published on 08 Feb 2021
mTOR Inhibitors as Radiosensitizers in Neuroendocrine Neoplasms
doi 10.3389/fonc.2020.578380
- 2,235 views
- 7 citations
ORIGINAL RESEARCH
Published on 30 Jun 2020
A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment
doi 10.3389/fonc.2020.00952
- 1,751 views
- 4 citations
ORIGINAL RESEARCH
Published on 21 Feb 2020
Tumor Contrast-Enhancement for Monitoring of PRRT 177Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients
doi 10.3389/fonc.2020.00193
- 2,732 views
- 8 citations
Published in
Frontiers in Oncology
- Cancer Imaging and Image-directed Interventions
Impact
- 15kTopic views
- 9,793Article views
- 4,695Article downloads